FinBoss.io
CSEN
  • Home
  • Crypto prices
  • Bitcoin on-chain
  • US macro
  • US stocks
  • Guides
  • How we make money
FinBoss.io
Home
Crypto prices
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Guides
How we make money
CSEN
Home
Stocks
Amgen Inc
AM

Amgen Inc

AMGNHealth care

Stock · Data from SEC EDGAR 13F · Held by 12 of 87 tracked investors

$439.26
▼ 1.79%
Famous investorshold 12buying 1selling 0
Price (USD)
$439.26
Market cap
$237B
P/E ratio
27.3
Tracked investors holding
12 of 87
Next earnings
–

Amgen Inc at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
78out of 100
  • Valuation53
  • Growth76
  • Profitability90
  • Quality95
  • Debt53
  • Stability100
In its favour
  • Out of 100 USD of revenue, 23 USD is left as net profit.

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 20264 Aug 20266.295.60+12.3%
Mar 202630 Apr 20265.154.73+8.9%
Dec 20253 Feb 20265.294.76+11.1%
Sep 20254 Nov 20255.645.00+12.8%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

7D
+1.57%
1M
+8.18%
3M
+16.81%
YTD
+34.07%
1Y
+50.56%
3Y
+67.93%
5Y
+112.23%
Forward P/E
17.9
Dividend yield
2.25%
52-week low
$288.00
52-week high
$450.98

Chart AMGN

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

12
Čn
Česká národní banka
Česká národní banka
0.35%$65,476,099▲ +1.1%
Šn
Švýcarská národní banka
Swiss National Bank
0.29%$550,564,713▼ -3.8%
GI
Generali Investments CEE
Generali Investments CEE
0.21%$4,415,328unchanged
Ns
Norský státní fond
Norges Bank
0.2%$2,037,136,478New position
KF
Ken Fisher
Fisher Investments
0.17%$575,609,596▲ +0.7%
JG
Joel Greenblatt
Gotham Asset Management
0.04%$16,875,154▼ -1.6%
CA
Cliff Asness
AQR Capital Management
0.04%$107,771,744▲ +97.1%
RD
Ray Dalio
Bridgewater Associates
0.03%$7,919,202▲ +48%
KG
Ken Griffin
Citadel Advisors
0.03%$254,926,687▲ +280.6%
MG
Mario Gabelli
GAMCO Investors
0.02%$1,672,270▼ -8.1%
IE
Israel Englander
Millennium Management
0.01%$28,732,049▼ -65.5%
JY
Jeff Yass
Susquehanna International Group
0.01%$116,122,831▲ +0.9%

Frequently asked questions

How much is Amgen Inc (AMGN) stock?

Amgen Inc shares trade at $439.26, -1.79% over the last trading day. The price is delayed.

What is the market cap of Amgen Inc?

The market cap of Amgen Inc is about $237B and its price-to-earnings ratio (P/E) is 27.3.

Does Amgen Inc pay a dividend?

The dividend yield of Amgen Inc is 2.25% a year. The yield can change with the company's decisions.

How has Amgen Inc stock performed over the last year?

The Amgen Inc share price changed by +50.56% over 12 months and by +112.23% over 5 years.

Which big investors hold Amgen Inc?

According to the latest 13F filings, 12 of 87 tracked investors hold Amgen Inc, for example Česká národní banka, Švýcarská národní banka, Generali Investments CEE.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms (Czech)Privacy (Czech)Cookies (Czech)

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

✓
  • ✓It earns 91 USD a year on every 100 USD of invested capital (ROE).
  • ✓Revenue grew 11.8% a year over 3 years.
  • What to watch
    • !Net debt is high: at the current free cash flow it would take 5 years to repay.

    The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

    Is the stock expensive?

    Reasonably priced

    For 1 USD of annual earnings you pay 27.3 USD. Based on next year's estimates 17.9 USD.

    P/E
    27.3×
    P/S
    6.2×
    EV/EBITDA
    16.3×

    Is the company growing?

    Growing
    22
    23
    24
    25

    Revenue over 3 years grew 11.8% a year. Last year 9.5%.

    Does it make money?

    Excellent
    • Cost of sales 33
    • Research 19.8
    • Operations and selling 22.8
    • Taxes and other 3.7
    • Net profit 21.0

    Out of 100 USD of revenue, 21.0 USD is left as net profit.

    Is it financially healthy?

    Mostly
    Cash
    14.0B USD
    Debt
    57.3B USD
    Free CF
    8.6B USD

    It could repay its net debt from free cash flow in 5.0 years.

    Does it pay a dividend?

    Pays
    Yield
    2.25%
    Of earnings
    61%

    Over a year you receive roughly 2.25% of the price per share. The payout is more demanding for the company. It has raised the dividend for 9 years in a row.

    What do analysts expect?

    Hold
    Average target
    396.70 USD
    Vs price
    −10%

    29 analysts. Their opinion is not a recommendation by FinBoss.io.

    Which big investors hold it?

    12 of 87

    Among the tracked investors, Česká národní banka, Švýcarská národní banka, Generali Investments CEE and others hold the stock according to 13F filings.

    Revenue and net profit (USD B)

    Margins (% of revenue)

    Free cash flow and capex (USD B)

    Cash and debt (USD B)

    Earnings per share (EPS, USD)

    Latest quarters (USD B)

    Dividend per share by year (USD)

    * the year has not ended yet. Source: Yahoo Finance.

    Ratios

    P/E
    27.3×
    Forward P/E
    17.9×
    P/B
    20.3×
    P/S
    6.2×
    PEG
    2.67
    EV/EBITDA
    16.3×
    Gross margin
    71.9%
    Operating margin
    35.5%
    Net margin
    23.0%
    ROE
    91.5%
    ROA
    8.7%
    Debt / equity
    4.9×
    Current ratio
    1.4×
    Revenue growth
    9.5%
    Earnings growth
    64.9%
    Beta
    0.41
    Dividend
    2.25%
    Payout ratio
    61%